Synthesis of 2- and 7- Substituted C19 Steroids Having a 1,4,6-Triene or 1,4-Diene Structure and Their Cytotoxic Effects on T47D and MDA-MB231 Breast Cancer Cells

2-Chloro-, 2-bromo- and 2-azido-1,4,6-androstatriene-3,17-diones were synthesized from 1α,2α-epoxy-4,6-androstadiene-3,17-dione (2) using HCl, HBr and NaN3, respectively. Compound 2 was also reacted with NaCN to give 2-cyano-1,4,6-androstatriene-3,17-dione (5) and 2β-cyano-1α-hydroxy-4,6-androstadiene-3,17-dione (6). 6α,7α-Epoxy-1,4-androstadiene-3,17-dione (8) was reacted with HCl, HBr and NaN3 to form the corresponding 7β-chloro-, 7β-bromo- and 7β-azido-6α-hydroxy-1,4-androstadiene-3,17-diones. The cytotoxic activity of these compounds towards T47D (estrogen-dependent) and MDA-MB231 (estrogen-independent) breast cancer cell lines was evaluated. The 6α-hydroxy-7β-substituted analogs were more active than the 2-substituted analogs on both cell lines. Compound 2 showed the highest selective activity against the T47D (IC507.1 μM) cell line and 5 showed good cytotoxic activity on MDA-MB231 (IC5018.5 μM) cell line, respectively. The 6α,7α-epoxy analog 8 also showed high cytotoxic activity on both cell lines (IC50 17.3 μM on T47D and IC50 26.9 μM on MDA-MB231).

[1]  S. Marsh,et al.  Pharmacokinetics and pharmacogenomics in breast cancer chemotherapy. , 2009, Advanced drug delivery reviews.

[2]  I. Zupkó,et al.  Efficient approach to androstene-fused arylpyrazolines as potent antiproliferative agents. Experimental and theoretical studies of substituent effects on BF(3)-catalyzed intramolecular [3 + 2] cycloadditions of olefinic phenylhydrazones. , 2009, Journal of the American Chemical Society.

[3]  M. Sikora,et al.  The androgen metabolite 5α-androstane-3β,17β-diol (3βAdiol) induces breast cancer growth via estrogen receptor: implications for aromatase inhibitor resistance , 2009, Breast Cancer Research and Treatment.

[4]  R. Bansal,et al.  Synthesis of 16E-[3-methoxy-4-(2-aminoethoxy)benzylidene]androstene derivatives as potent cytotoxic agents , 2008, Steroids.

[5]  A. McEwan,et al.  Synthesis and evaluation of novel 4-amino-4,6-androstadiene-3,17-dione: an analog of formestane. , 2008, Bioorganic & medicinal chemistry letters.

[6]  V. Kojić,et al.  Synthesis of some epoxy and/or N-oxy 17-picolyl and 17-picolinylidene-androst-5-ene derivatives and evaluation of their biological activity , 2008, Steroids.

[7]  V. Paz,et al.  Synthesis and evaluation of new 6-hydroximinosteroid analogs as cytotoxic agents. , 2007, Bioorganic & medicinal chemistry.

[8]  Z. Zizak,et al.  Synthesis of some steroidal oximes, lactams, thiolactams and their antitumor activities , 2007, Steroids.

[9]  E. Ma,et al.  Epoxidation and Reduction of DHEA, 1,4,6-Androstatrien-3-one and 4,6-Androstadien-3β,17β-diol , 2005, Molecules.

[10]  D. P. Jindal,et al.  Synthesis and antineoplastic activity of 2-alkylaminoethyl derivatives of various steroidal oximes. , 2003, European journal of medicinal chemistry.

[11]  S. Yamaguchi,et al.  Synthesis and structure–activity relationships of 6-phenylaliphatic-substituted C19 steroids having a 1,4-diene, 4,6-diene, or 1,4,6-triene structure as aromatase inhibitors , 1999, Steroids.

[12]  R. D. Williams,et al.  Oxythiamine and dehydroepiandrosterone inhibit the nonoxidative synthesis of ribose and tumor cell proliferation. , 1997, Cancer research.

[13]  W. Duax,et al.  Synthesis, Structure Elucidation, and Biochemical Evaluation of 7. alpha.‐ and 7β‐Arylaliphatic‐Substituted Androst‐4‐ene‐3,17‐ diones as Inhibitors of Aromatase. , 1995 .

[14]  W. Duax,et al.  Synthesis, structure elucidation, and biochemical evaluation of 7 alpha- and 7 beta-arylaliphatic-substituted androst-4-ene-3,17-diones as inhibitors of aromatase. , 1995, Journal of medicinal chemistry.

[15]  M. Muroni,et al.  Inhibition by dehydroepiandrosterone of growth and progression of persistent liver nodules in experimental rat liver carcinogenesis , 1995, International journal of cancer.

[16]  M. Hedge,et al.  Aromatase inhibitors: Effect of ring A and ring B unsaturation on aromatase inhibition by 4-thiosubstituted derivatives of 4-androstene-3,17-dione , 1995, Steroids.

[17]  A. Brodie,et al.  Aromatase inhibitors in the treatment of breast cancer , 1994, The Journal of Steroid Biochemistry and Molecular Biology.

[18]  S. Sadekova,et al.  Identification of the aromatase in the breast carcinoma cell lines T47D and MCF-7. , 1994, Anticancer Research.

[19]  M. Gervais,et al.  6-Hydroximinoandrostenedione, a new specific inhibitor of estrogen biosynthesis and its effect on T47D human breast cancer cells. , 1993, Anticancer Research.

[20]  J. Nyce,et al.  Mechanisms of cell growth inhibition and cell cycle arrest in human colonic adenocarcinoma cells by dehydroepiandrosterone: role of isoprenoid biosynthesis. , 1992, Cancer research.

[21]  G. Kelloff,et al.  Inhibition of rat mammary gland chemical carcinogenesis by dietary dehydroepiandrosterone or a fluorinated analogue of dehydroepiandrosterone. , 1991, Cancer research.

[22]  J. Kellis,et al.  Purification and characterization of human placental aromatase cytochrome P-450. , 1987, The Journal of biological chemistry.

[23]  P. Magee,et al.  Inhibition of 1,2-dimethylhydrazine-induced colon tumorigenesis in Balb/c mice by dehydroepiandrosterone. , 1984, Carcinogenesis.

[24]  A. Schwartz,et al.  Inhibition of 7,12-dimethylbenz[a]anthracene- and urethan-induced lung tumor formation in A/J mice by long-term treatment with dehydroepiandrosterone. , 1981, Carcinogenesis.

[25]  B. Pelc,et al.  Steroid derivatives. XLIV. Further reactions of 1α,2α-epoxy-3-ketones of androstane series , 1967 .